Paroxysmal Atrial Fibrillation and Administration of Antiplatelet Therapy Are Still Negative Determinants of Warfarin Use in Non-Valvular Atrial Fibrillation Patients Treated by Japanese Cardiologists

Circulation Journal - Japan
doi 10.1253/circj.cj-11-0920
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Circulation Society

Related search

Under-Use of Warfarin for Patients With Non-Valvular Atrial Fibrillation in Japan

Internal Medicine
Internal MedicineMedicine
2004English

Thromboembolic Events in Paroxysmal vs. Permanent Non-Valvular Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation

Archives of Internal Medicine
2012English

Comparative Pharmacoeconomic Analysis of Rivaroxaban and Warfarin Usage in Patients With Non-Valvular Atrial Fibrillation

Jounal of arrhythmology
2020English

Adherence to Medication and Characteristics of Japanese Patients With Non-Valvular Atrial Fibrillation

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Effect and Risk of Novel Oral Anticoagulants Versus Warfarin in Patients With Non-Valvular Atrial Fibrillation

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Paroxysmal Atrial Fibrillation: Choice of Cardioversion Therapy

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2007English

Incidence of Major Bleeding Complication of Warfarin Therapy in Japanese Patients With Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2007English

Suboptimal Oral Anticoagulant Treatment Among Chinese Non-Valvular Atrial Fibrillation Patients: The Nanchang Atrial Fibrillation Project

Archives of Medical Science
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy